Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal JURNAL ILMIAH KESEHATAN SANDI HUSADA Jurnal Ilmiah Kesehatan Sandi Husada
Komang Dendi Juliawan
Unknown Affiliation
Health Professions Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
RTS,S/AS01 sebagai Vaksin Malaria Generasi Pertama Komang Dendi Juliawan
Jurnal Ilmiah Kesehatan Sandi Husada Vol 8 No 2 (2019): Jurnal Ilmiah Kesehatan Sandi Husada
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Akademi Keperawatan Sandi Karsa (Merger) Politeknik Sandi Karsa

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35816/jiskh.v10i2.170

Abstract

Malaria is an infectius disease caused by Plasmodium sp. The treatment for malaria with Artemisinin-based Combination Therapy (ACT) can cause resistance so a new effort is needed to reduce the morbidity of malaria. A better prevention method for preventing malaria is to use vaccines. The RTS,S/AS01 vaccine is the first generation malaria vaccine that has been applied in Ghana, Kenya and Malawi since early 2018. The vaccine consists of circumsporozoite protein antigen and hepatitis B. This vaccine has been shown to provide partial protection to children and has reach efficacy by 80%.
RTS,S/AS01 sebagai Vaksin Malaria Generasi Pertama Komang Dendi Juliawan
Jurnal Ilmiah Kesehatan Sandi Husada Vol 8 No 2 (2019): Jurnal Ilmiah Kesehatan Sandi Husada
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat Akademi Keperawatan Sandi Karsa (Merger) Politeknik Sandi Karsa

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35816/jiskh.v10i2.170

Abstract

Malaria is an infectius disease caused by Plasmodium sp. The treatment for malaria with Artemisinin-based Combination Therapy (ACT) can cause resistance so a new effort is needed to reduce the morbidity of malaria. A better prevention method for preventing malaria is to use vaccines. The RTS,S/AS01 vaccine is the first generation malaria vaccine that has been applied in Ghana, Kenya and Malawi since early 2018. The vaccine consists of circumsporozoite protein antigen and hepatitis B. This vaccine has been shown to provide partial protection to children and has reach efficacy by 80%.
Co-Authors